Adaptable: The Aspirin Study
10 March, 2016

Adaptable: The Aspirin Study

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

Learn More
LEAD Study: Louisiana Experiment Assessing Diabetes Outcomes
9 March, 2016

LEAD Study: Louisiana Experiment Assessing Diabetes Outcomes

The LEAD Study is a prospective observational study examining the impacts of Medicare reimbursement for non-face-to-face chronic care management services on health outcomes among patients with diabetes. Tulane University is leading this project in collaboration with REACHnet partner health systems and payer organizations in Louisiana.

The LEAD Study is a prospective observational study examining the impacts of Medicare reimbursement for non-face-to-face chronic care management services on health outcomes among patients with diabetes. Tulane University is leading this project in collaboration with REACHnet partner health systems and payer organizations in Louisiana.

Learn More